Essex pharma GmbH Company Profile
Nil
Location
Thomas-Dehler-Straße 27
München
81737
Germany
Contact
Phone: 49 (0) 89 / 6 27 31 - 0
Fax: 49 (0) 89 / 6 27 31 - 499
Email: info@essex-pharma.de
News Articles
Essex IRB OKed trial from a fake pharma and failed to ensure patient safety, says FDA
New Jersey, US based Essex IRB approved a study protocol submitted by a fictitious sponsor and failed to adhere to rules designed to protect trial participants according to an FDA warning letter.
Antony John Essex-Cater (“Tony”) did his national service in the Royal Air Force and entered public health in Croydon before touring the country with posts in Swansea, Birmingham, Manchester, and....
Verizon Wireless Expands 4G LTE Coverage In Essex County, Virginia
LAUREL, Md., March 29, 2013 /PRNewswire/ --Verizon Wireless has activated new fourth generation (4G) Long Term Evolution (LTE) network coverage in Essex County, Virginia with the addition of a new...
Supporting Doctors With The Ethical And Legal Challenges Of Determining 'Best Interests'
Doctors taking decisions on the 'best interests' of incapacitated patients also need to take into account the interests of others when making their assessments according to researchers on the Essex Au...
Essex Woodlands Opens China Office to Fund Healthcare Deals
Essex Woodlands, a US-based growth capital firm that invests only in healthcare companies, has opened an office in Shanghai. The Shanghai office will lead the company’s China practice, focusin...
Care Homes Essex - Showing the Carers That We Care
LONDON, January 17, 2013 /PRNewswire/ -- Carers' Rights Day came under the spotlight in Care UK's Halstead's care home - Colne View, (http://www.careuk.com/colne-view) with an event designed to help...
Revance closes $33 million series E
Revance Therapeutics Inc. (Newark, Calif.) raised $33 million in a series E round led by existing investors NovaQuest Pharma and Essex Woodlands. New investor Delphi Ventures also participated, along...
Pharma 3.0 Pulls Companies into the Digital Future
Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0. Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drug...
Drugs and Medications
Eloxatin [Aventis Pharma Ltd.]
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 0.5 mg
Fluoride [Libertas Pharma, Inc.]
Fluoride Chewable Tablets 1 mg
Metoprolol tartrate [Med-Health Pharma, LLC]
Metoprolol Tartrate Tablets, USP
Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )
PubMed Articles
Paravertebral cervical chordoma - a case report.
Chordomas constitute
Rethinking innovative designs to further test parasite-stress theory.
Fincher & Thornhill's (F&T's) parasite-stress theory of sociality is supported largely by correlational evidence; its persuasiveness would increase significantly via lab and natural experiments and de...
Warm-up effects on muscle oxygenation, metabolism and sprint cycling performance.
To investigate the effects of warm-up intensity on all-out sprint cycling performance, muscle oxygenation and metabolism, 8 trained male cyclists/triathletes undertook a 30-s sprint cycling test prece...
Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...
Clinical Trials
To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.
Pharma-Pen (Formerly Innoject) Auto-Injectory TIV
The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...
To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions
To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.
This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...
Development of a New Method for Analgesia
Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.
Companies
Nil
Essex Woodlands was founded in 1985 when it raised its first fund, Essex Venture Partners Fund I. Since that time, the Partnership has raised five additional funds and has managed over $1 billion in p...
H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...
Nil
LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...
More Information about "Essex pharma GmbH" on BioPortfolio
We have published hundreds of Essex pharma GmbH news stories on BioPortfolio along with dozens of Essex pharma GmbH Clinical Trials and PubMed Articles about Essex pharma GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Essex pharma GmbH Companies in our database. You can also find out about relevant Essex pharma GmbH Drugs and Medications on this site too.